Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Jack Ucci who wrote (946)	6/18/1998 9:48:00 AM
From: Jack Ucci	Respond to of 1605

All: A heart surgery study. The Post-Standard, a local Newspaper in Syracuse, NY had a brief article on the above, the gist of which follows. The New England Journal of Medicine published this week a study by a Syracuse cardiologist. Dr. W. Boden's research shows that angioplasties, catheterizations and other common treatments for heart attacks are not always the best treatment; that patients treated with exercise and medications lived as long as other patients once they were sent home from the hospital. The $3.7 mil study involved a team of doctors at VA medical centers across the country treating 920 patients with heart attack symptoms between 1993 and 1995. Most vets are men so very few female patients were in the study. A new $30 mil study will start in October and involve both men and women. No mention of EECP, which is intended to simulate the effects of exercise. Jack